These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Comparison of nicorandil-induced relaxation, elevations of cyclic guanosine monophosphate and stimulation of guanylate cyclase with organic nitrate esters. Greenberg SS; Cantor E; Ho E; Walega M J Pharmacol Exp Ther; 1991 Sep; 258(3):1061-71. PubMed ID: 1679847 [TBL] [Abstract][Full Text] [Related]
4. The discovery of nitric oxide as the endogenous nitrovasodilator. Moncada S; Palmer RM; Higgs EA Hypertension; 1988 Oct; 12(4):365-72. PubMed ID: 3049340 [TBL] [Abstract][Full Text] [Related]
5. Desensitization of guanylate cyclase in nitrate tolerance does not impair endothelium-dependent responses. Mülsch A; Busse R; Bassenge E Eur J Pharmacol; 1988 Dec; 158(3):191-8. PubMed ID: 2908105 [TBL] [Abstract][Full Text] [Related]
6. Nitric oxide and nitrovasodilators: similarities, differences and potential interactions. Anderson TJ; Meredith IT; Ganz P; Selwyn AP; Yeung AC J Am Coll Cardiol; 1994 Aug; 24(2):555-66. PubMed ID: 8034895 [TBL] [Abstract][Full Text] [Related]
7. Halothane and isoflurane inhibit endothelium-derived relaxing factor-dependent cyclic guanosine monophosphate accumulation in endothelial cell-vascular smooth muscle co-cultures independent of an effect on guanylyl cyclase activation. Johns RA; Tichotsky A; Muro M; Spaeth JP; Le Cras TD; Rengasamy A Anesthesiology; 1995 Oct; 83(4):823-34. PubMed ID: 7574063 [TBL] [Abstract][Full Text] [Related]
8. Halothane attenuates nitric oxide relaxation of rat aortas by competition for the nitric oxide receptor site on soluble guanylyl cyclase. Jing M; Ling GS; Bina S; Hart JL; Muldoon SM Eur J Pharmacol; 1998 Jan; 342(2-3):217-24. PubMed ID: 9548389 [TBL] [Abstract][Full Text] [Related]
9. Coronary vasomotor responses: role of endothelium and nitrovasodilators. Bassenge E Cardiovasc Drugs Ther; 1994 Aug; 8(4):601-10. PubMed ID: 7531489 [TBL] [Abstract][Full Text] [Related]
10. Clinical tolerance to nitroglycerin is due to impaired biotransformation of nitroglycerin and biological counterregulation, not to desensitization of guanylate cyclase. Mülsch A; Busse R; Bassenge E Z Kardiol; 1989; 78 Suppl 2():22-5; discussion 64-7. PubMed ID: 2573982 [TBL] [Abstract][Full Text] [Related]
11. Endothelium- and sydnonimine-induced responses of native and cultured aortic smooth muscle cells are not impaired by nitroglycerin tolerance. Mülsch A; Busse R; Winter I; Bassenge E Naunyn Schmiedebergs Arch Pharmacol; 1989 May; 339(5):568-74. PubMed ID: 2570362 [TBL] [Abstract][Full Text] [Related]
12. Human endothelial cells bioactivate organic nitrates to nitric oxide: implications for the reinforcement of endothelial defence mechanisms. Feelisch M; Brands F; Kelm M Eur J Clin Invest; 1995 Oct; 25(10):737-45. PubMed ID: 8557060 [TBL] [Abstract][Full Text] [Related]
16. [Nitric oxide-dependent endogenous and exogenous vasodilators. The mechanism of action of nitrates]. Machado AP; Alcântara P Rev Port Cardiol; 1995 Jan; 14(1):61-71. PubMed ID: 7695956 [TBL] [Abstract][Full Text] [Related]
17. Nitric oxide and nitrovasodilators: similarities, differences, and interactions. Kelly RA; Smith TW Am J Cardiol; 1996 May; 77(13):2C-7C. PubMed ID: 8638522 [TBL] [Abstract][Full Text] [Related]
18. Endothelium-derived relaxing factor from pulmonary artery and vein possesses pharmacologic and chemical properties identical to those of nitric oxide radical. Ignarro LJ; Byrns RE; Buga GM; Wood KS Circ Res; 1987 Dec; 61(6):866-79. PubMed ID: 2890446 [TBL] [Abstract][Full Text] [Related]
20. Mechanisms of action of the organic nitrates in the treatment of myocardial ischemia. Abrams J Am J Cardiol; 1992 Sep; 70(8):30B-42B. PubMed ID: 1529924 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]